New Zealand Clinical Research - Christchurch
Christchurch, New Zealand
2 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
Metastatic Castration-resistant Prostate Cancer
Telix Pharmaceuticals (Innovations) Pty Limited520 enrolled31 locationsNCT06520345
Recruiting
Phase 2
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Type 1 Diabetes
SAb Biotherapeutics, Inc.159 enrolled71 locationsNCT07187531
Recruiting
Phase 1
A Dose-Escalation Study of RO7875913 in Healthy Participants
Healthy Volunteers
Genentech, Inc.40 enrolled1 locationNCT07342114
Recruiting
Phase 1
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants
Healthy Volunteers
Hoffmann-La Roche128 enrolled1 locationNCT07271693
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
Neoplasms
Hoffmann-La Roche405 enrolled21 locationsNCT06884618